Pursuant to the requirement of Regulation of 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has confirmed that all activities, for financial year ended March 31, 2023, in relation to share transfer facility are maintained by Abhipra Capital (Registrar and Share Transfer Agent of the Company which is registered with the SEBI). Copy of Certificate issued by Abhipra Capital is enclosed.
The above information is a part of company’s filings submitted to BSE.
